Onconova Therapeutics, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Onconova Therapeutics, Inc.
Quantité totale PI 43
Rang # Quantité totale PI 33 233
Note d'activité PI 2,3/5.0    25
Rang # Activité PI 31 587
Symbole boursier ONTX (nasdaq)
ISIN US68232V8019
Capitalisation 20.90M  (USD)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

13 0
7 0
23 0
0
 
Dernier brevet 2024 - Methods and compositions for tre...
Premier brevet 2002 - Method for protecting cells and ...

Derniers inventions, produits et services

2024 Invention Methods and compositions for treating cancer. Disclosed herein is a method of treating endometri...
Invention Methods and compositions for treating cancer. Disclosed herein is a method of treating ovarian c...
Invention Methods and compositions for treating cancer. Disclosed herein is a method of treating a cancer ...
Invention Methods and compositions for treating cancer. RAS proteins are frequently mutated in human cancer...
2023 Invention Methods and compositions for treating cancer. Disclosed herein is a method of treating breast can...
Invention Methods and compositions for treating cancer. Disclosed herein is a method for treating endometri...
Invention Methods and compositions for treating cancer. Disclosed herein is a method of treating lymphoma b...
Invention Methods and compositions for treating cancer. Disclosed herein is a method of treating a cancer b...
2022 Invention Methods and compositions for treating cancer. Disclosed herein is a method of treating ovarian ca...
Invention Methods and compositions for treating cancer. Disclosed herein is a method of treating endometria...
Invention Methods and compositions for treating cancer. Disclosed herein is a method of treating a cancer i...
Invention Methods and compositions for treating cancer. Disclosed herein is a method of treating a squamous...
2018 Invention 8-cyclopentyl-7-oxo-2-(4-piperazin-1-yl-phenylamino)-7, 8-dihydro-pyrido [2,3-d]pyrimidine-6-carb...
2017 Invention Formulation of (e)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4- methoxybenzylsulphone with ...
2015 Invention Stable aqueous formulation of (e)-4-carboxystyryl-4-chlorobenzyl sulfone. An aqueous pharmaceutic...
Invention Formulation of radioprotective alpha, beta unsaturated aryl sulfones. Solution and suspension fo...
2014 Invention Methods and compositions for predicting therapeutic efficacy of kinase inhibitors in patients wit...
2013 Invention Methods and compositions for treatment of cancer. The invention discloses a method of treating ca...
2011 Invention Compositions and methods for prevention and treatment of wounds. The present invention provides c...
Invention Improved stable aqueous formulation of (e)-4-carboxystyryl-4-chlorobenzyl sulfone. An aqueous pha...
2009 Invention Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxi...
Invention Treatment of proliferative disorders with amino-substituted (e)-2,6- dialkoxystyryl 4-substituted...
2008 Invention Formulations for parenteral administration of amino-substituted (e)-2, 6-dialkoxystyryl 4-substit...
Invention Formulations for parenteral administration of (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones...
2007 Invention Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalia...
Invention Formulations of radioprotective alpha beta unsaturated aryl sulfones. Solution and suspension fo...
Invention Formulations of radioprotective α, β unsaturated aryl sulfones. Solution and suspensio...
2006 Invention Formulation of radioprotective alpha beta unsaturated aryl sulfones. A pharmaceutical compositio...
Invention Formulation of radioprotective &agr;, &bgr; unsaturated aryl sulfones. A pharmaceutical compositi...
Invention Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis. α,β-Unsaturated sulfides, ...
Invention Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis. &agr;,&bgr;-Unsaturated su...
2005 Invention Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfone...
Invention Formulations for parenteral administration of (e)-2,6-dialkoxystryryl 4-substituted benzylsulfone...
Invention Substituted phenoxy-and phenylthio-derivatives for treating proliferative disorders. Substituted ...
Invention Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders. Substitute...
2004 Invention Alpha, beta-unsaturated sulfoxides for treating proliferative disorders. &agr;&bgr;-Unsaturated s...
Invention Processes for the preparation of substituted isoxazoles and 2-isoxazolines. Provided are compound...
Invention (-)1-(4-sulfamylaryl)-3-substituted-5-heteroaryl-2 pyrazolines as inhibitors of cyclooxygenase-2....
2003 Invention E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders. 7, g, M,...
Invention Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders. 3 ...